5beta-Cholanoic acid

5beta-cholanoic acid is a lipid of Sterol Lipids (ST) class. The involved functions are known as Vasodilation and Intestinal Absorption. The associated genes with 5beta-Cholanoic acid are iberiotoxin.

Cross Reference

Introduction

To understand associated biological information of 5beta-Cholanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 5beta-Cholanoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

What functions are associated with 5beta-Cholanoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with 5beta-Cholanoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 5beta-Cholanoic acid

Download all related citations
Per page 10 20 50 100 | Total 70
Authors Title Published Journal PubMed Link
Chevrie K et al. Dye-hydrophobic hapten conjugate/anti-dye antibody complex as immunogen: preparation of hydrophobic hapten-specific monoclonal antibodies. 1994 Biochimie pmid:8043652
Sqalli-Houssaini H et al. Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways. 1994 Biotechnol Ther pmid:7703834
Campanella L et al. Cholanic acids determined in commercial drugs by means of a new ISFET device. 1993 Nov-Dec J Pharm Biomed Anal pmid:8123735
Fantin G et al. Synthesis of 7- and 12-hydroxy- and 7,12-dihydroxy-3-keto-5 beta-cholan-24-oic acids by reduction of 3,7-, 3,12- and 3,7,12-oxo derivatives. 1993 Steroids pmid:8273114
Yoshimura T et al. An efficient synthesis of 4 beta- and 6 alpha-hydroxylated bile acids. 1993 Steroids pmid:8484184
Mori Y et al. Absence of mutagenic action of 5 beta-cholan-24-oic acid derivatives in the bacterial fluctuation and standard Ames tests. 1991 Mutat. Res. pmid:2017224
Allevi P et al. Synthesis of 7 alpha,12 alpha-dihydroxy-3 alpha- [2-(beta-D-glucopyranosyl)acetyl]-5 beta-cholan-24-oic acid. 1990 Steroids pmid:2219197
Sawada K et al. Promoting effect of 5 beta-chol-3-en-24-oic acid on N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. 1987 Jpn. J. Cancer Res. pmid:3117746
Eto T and Tompkins RK Further studies on the inhibition of pepsin by bile salts. 1986 Ann. Surg. pmid:3079997
Lawson AM et al. Rapid diagnosis of Zellweger syndrome and infantile Refsum's disease by fast atom bombardment--mass spectrometry of urine bile salts. 1986 Clin. Chim. Acta pmid:2433077